Skip to main content
1 May 2025
Last updated:
Tuesday 29 April 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Why health technology assessment is here to stay
Read more
Oncology review for 2011
Read more
How cannabis medicines gained legitimacy
Read more
UK Biotech needs a subtle culture shift
Read more
Investment pendulum swings back towards biotech
Read more
Europe to tackle antimicrobial resistance
Read more
The perilous state of antibiotic development
Read more
Risk sharing with Pharma -- is this the way to go?
Read more
ADCs propelled back into the oncology spotlight
Read more
Why Oxford BioTherapeutics is targeting ADCs
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
65
Page
66
Page
67
Page
68
Current page
69
Page
70
Page
71
Page
72
Page
73
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
